Personal comment:
I fully share the concerns set out in this BMJ response. Alas, Scotland seems to be all set to ‘go’:
Keynote Lecture, 2023 for Alzheimer’s Scotland:
Scottish Brain Sciences [you will find ‘recruitment’ adverts in many newspapers]:
If you are interested in ‘joining the world’s first Brain Health Community’ I would recommend that you undertake as much research as you can before you do so. Here are some relevant posts:
- Blazing trails or the road to nowhere?
- Scottish Brain Sciences
- Anti-amyloid drugs: Key questions
- ‘Therapy related brain damage’
- Accelerated approval of an anti-amyloid drug
- “The data point to beta-amyloid playing a minor aetiological role”
- “The hyperbole in the media and scientific response is unjustified and cruel to patients”
- Donanemab: bleeding and Seizures
- Brain volume loss due to Donanemab
- Issues not considered in the ‘Edinburgh Consensus’
- The ‘Edinburgh Consensus’: A timeline
- Snakes, Ladders and Monopoly